Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
- PMID: 28483762
- PMCID: PMC5553576
- DOI: 10.1182/blood-2017-02-769869
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Abstract
Clonal hematopoiesis (CH) arises when a substantial proportion of mature blood cells is derived from a single dominant hematopoietic stem cell lineage. Somatic mutations in candidate driver (CD) genes are thought to be responsible for at least some cases of CH. Using whole-genome sequencing of 11 262 Icelanders, we found 1403 cases of CH by using barcodes of mosaic somatic mutations in peripheral blood, whether or not they have a mutation in a CD gene. We find that CH is very common in the elderly, trending toward inevitability. We show that somatic mutations in TET2, DNMT3A, ASXL1, and PPM1D are associated with CH at high significance. However, known CD mutations were evident in only a fraction of CH cases. Nevertheless, the highly prevalent CH we detect associates with increased mortality rates, risk for hematological malignancy, smoking behavior, telomere length, Y-chromosome loss, and other phenotypic characteristics. Modeling suggests some CH cases could arise in the absence of CD mutations as a result of neutral drift acting on a small population of active hematopoietic stem cells. Finally, we find a germline deletion in intron 3 of the telomerase reverse transcriptase (TERT) gene that predisposes to CH (rs34002450; P = 7.4 × 10-12; odds ratio, 1.37).
© 2017 by The American Society of Hematology.
Conflict of interest statement
Conflict-of-interest disclosure: All deCODE authors are employees of the biotechnology company deCODE genetics/AMGEN.
Figures





Comment in
-
Prevalent premalignancy.Blood. 2017 Aug 10;130(6):695-696. doi: 10.1182/blood-2017-05-786210. Blood. 2017. PMID: 28798057 No abstract available.
Similar articles
-
CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.Circ Res. 2018 Jul 20;123(3):335-341. doi: 10.1161/CIRCRESAHA.118.313225. Epub 2018 May 4. Circ Res. 2018. PMID: 29728415 Free PMC article.
-
DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.Blood. 2017 Aug 10;130(6):753-762. doi: 10.1182/blood-2017-04-777029. Epub 2017 Jun 27. Blood. 2017. PMID: 28655780
-
Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.Exp Hematol. 2016 Sep;44(9):857-865.e5. doi: 10.1016/j.exphem.2016.05.009. Epub 2016 May 26. Exp Hematol. 2016. PMID: 27235757 Free PMC article.
-
[Clonal haematopoiesis: A concise review].Rev Med Interne. 2019 Oct;40(10):684-692. doi: 10.1016/j.revmed.2019.05.005. Epub 2019 May 22. Rev Med Interne. 2019. PMID: 31126662 Review. French.
-
Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.J Cell Physiol. 2019 Jun;234(6):8396-8401. doi: 10.1002/jcp.27752. Epub 2018 Nov 11. J Cell Physiol. 2019. PMID: 30417440 Review.
Cited by
-
Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.Cancer Res. 2022 Nov 15;82(22):4107-4113. doi: 10.1158/0008-5472.CAN-22-0985. Cancer Res. 2022. PMID: 36040522 Free PMC article.
-
Association Between Aortic Valve Sclerosis and Clonal Hematopoiesis of Indeterminate Potential.Ann Lab Med. 2024 May 1;44(3):279-288. doi: 10.3343/alm.2023.0268. Epub 2024 Jan 11. Ann Lab Med. 2024. PMID: 38205526 Free PMC article.
-
The role of clonal haematopoiesis in cardiovascular diseases: epidemiology and experimental studies.J Intern Med. 2020 Nov;288(5):507-517. doi: 10.1111/joim.13130. Epub 2020 Jul 27. J Intern Med. 2020. PMID: 32715520 Free PMC article. Review.
-
CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors.Clin Cancer Res. 2023 Apr 14;29(8):1403-1411. doi: 10.1158/1078-0432.CCR-22-2598. Clin Cancer Res. 2023. PMID: 36454121 Free PMC article. Review.
-
Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma.PLoS One. 2022 Dec 1;17(12):e0278464. doi: 10.1371/journal.pone.0278464. eCollection 2022. PLoS One. 2022. PMID: 36454786 Free PMC article.
References
-
- Busque L, Mio R, Mattioli J, et al. . Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood. 1996;88(1):59-65. - PubMed
-
- Fey MF, Liechti-Gallati S, von Rohr A, et al. . Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood. 1994;83(4):931-938. - PubMed
-
- Gale RE, Wheadon H, Linch DC. X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females. Br J Haematol. 1991;79(2):193-197. - PubMed
-
- Champion KM, Gilbert JG, Asimakopoulos FA, Hinshelwood S, Green AR. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol. 1997;97(4):920-926. - PubMed